Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis

ClinicalTrials.gov ID: NCT04279769

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04279769. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 6:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 1b multiple ascending dose escalation study to evaluate the safety and tolerability of arginase inhibitor CB-280 in subjects with cystic fibrosis.

Study identification

NCT ID
NCT04279769
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Calithera Biosciences, Inc
Industry
Enrollment
32 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 3, 2020 (Actual)
Primary completion
Nov 23, 2021 (Actual)
Completion
Nov 23, 2021 (Actual)
Last update posted
Apr 13, 2022

2020 – 2021

United States locations

U.S. sites
17
U.S. states
17
U.S. cities
17
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Long Beach Memorial Medical Center Long Beach California 90806 —
University of Florida Gainesville Florida 32610 —
The Cystic Fibrosis Institute Glenview Illinois 60025 —
Indiana University Indianapolis Indiana 46202 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Johns Hopkins University Baltimore Maryland 21287 —
Boston Children's Hospital, Brigham & Women's Hospital Boston Massachusetts 02115 —
Billings Clinic Billings Montana 59101 —
New York Medical College at Westchester Medical Center Hawthorne New York 10532 —
UNC Marsico Clinical Research Center Chapel Hill North Carolina 27514 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Hershey Medical Center Pennsylvania State University Hershey Pennsylvania 17033 —
Medical University of South Carolina Charleston South Carolina 29425 —
University of Utah Salt Lake City Utah 84132 —
Vermont Lung Center at the University of Vermont Medical Center Colchester Vermont 05446 —
Virginia Commonwealth University Richmond Virginia 23219 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04279769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2022 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.